Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Table of contents

October 1997 - Volume 52 - 10

Salbutamol enantiomers: early clinical evidence in humans. (1 October, 1997)
P W Ind
Ischaemia/reperfusion, inflammatory responses and acute lung injury. (1 October, 1997)
G M Rocker
Obstructive sleep apnoea: a progressive disorder? (1 October, 1997)
P M Calverley
Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. (1 October, 1997)
D W Cockcroft, V A Swystun
Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. (1 October, 1997)
B J Lipworth, D J Clark, P Koch, C Arbeeny
Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. (1 October, 1997)
A F Wisniewski, S A Lewis, D J Green, W Maslanka, H Burrell, A E Tattersfield
Attenuation of propranolol-induced bronchoconstriction by frusemide. (1 October, 1997)
J D Myers, M A Higham, B H Shakur, M Wickremasinghe, P W Ind
Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators. (1 October, 1997)
P G Raijmakers, A B Groeneveld, J A Rauwerda, G J Teule, C E Hack
Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. (1 October, 1997)
S T Pendlebury, J L Pépin, D Veale, P Lévy
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. (1 October, 1997)
R Harper, J E Brazier, J C Waterhouse, S J Walters, N M Jones, P Howard
Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. (1 October, 1997)
A Wangoo, R J Shaw, T C Diss, P J Farrell, R M du Bois, A G Nicholson
Risk of malignant neoplasms in patients with pulmonary sarcoidosis. (1 October, 1997)
N Seersholm, J Vestbo, K Viskum
Relation of fetal growth to adult lung function in south India. (1 October, 1997)
C E Stein, K Kumaran, C H Fall, S O Shaheen, C Osmond, D J Barker
Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. (1 October, 1997)
M Robinson, A L Hemming, J A Regnis, A G Wong, D L Bailey, G J Bautovich, M King, P T Bye
Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. (1 October, 1997)
D P Strachan, D G Cook
Erythromycin and diffuse panbronchiolitis. (1 October, 1997)
H Koyama, D M Geddes
Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? (1 October, 1997)
R Polosa, S T Holgate
Proteoglycans: the "Teflon" of the airways? (1 October, 1997)
C P Page
Three cases of meningococcal pneumonia. (1 October, 1997)
E M Jones, N M Brown, J E Harvey, D S Reeves, A P MacGowan
Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae. (1 October, 1997)
M M Pizzichini, E Pizzichini, A Efthimiadis, L Clelland, J B Mahony, J Dolovich, F E Hargreave
Increase in incidence of childhood empyema. (1 October, 1997)
S D Playfor, A R Smyth, R J Stewart
Asthma guidelines. (1 October, 1997)
S Rajan